Landcatch Natural Selection is the Aquaculture Breeding division of Hendrix Genetics. 

LNS was bought by Hendrix Genetics in 2010, launching our expansion into the exciting world of aquaculture through a new business division.
Hendrix selected LNS for its growth potential based on its market-leading expertise in producing high-performance salmon eggs and smolts (juvenile fish) and for its advanced scientific breeding services.

Based in Scotland and operating worldwide, the company has pioneered vital aspects of resistance in salmon to common diseases and infection from parasitic sea lice as well as improving growth and feed conversion efficiency.
In the last decade, LNS has racked up an impressive series of breakthroughs in these areas, starting in 2001 when it recognised resistance to Pancreas Disease in its salmon strain.

Since then, its breeding technology advances have come thick and fast, including being the first aquaculture company to pinpoint a major gene influencing Infectious Pancreatic Necrosis, then applying this discovery in selective breeding.

LNS has moved on to prove that sea lice resistance is inherited, with variations in family groups, and has now produced juvenile fish directly from broodstock and eggs selected for improved resistance. It is also developing a cutting-edge genomic selection tool for Atlantic salmon – the SNP chip – to accelerate this progress.
LNS, with its unrivalled in-house breeding science capability, already provides its high-performance eggs, smolts and genetic services to businesses from Europe to Chile.
Now, as part of the Hendrix family, LNS is developing to serve a much bigger and wider range of aquaculture customers, helping to fulfill the overall company mission to be a global champion in sustainable animal protein production.

Visit the website of Landcatch Natural Selection.